Healx Limited operates as a biotechnology company. The Company develops pharmaceutical products to find new therapeutic solutions for patients with rare diseases. Healx serves patients in the United Kingdom.
2019 • Series B
Healx is transforming the rare disease treatment path for patients and their doctors by generating insights and enabling actionable recommendations that drive improved outcomes.
Winning pitch decks that have closed millions in investments for leading startups and billion-dollar unicorns.
Investors see 5,000 pitch decks per year. Will you stand out?
No spam. Up to 2 emails/mo – only the good stuff!